Evotec SE (EVO) Minority Interest (2009 - 2010)
Evotec SE (EVO) posted Minority Interest of $675.34 for Q3 2010, down 34.36% sequentially from $1028.8 in Q2 2010.
Evotec SE (EVO) Minority Interest (2009 - 2010) Analysis & Trends
Evotec SE has reported Minority Interest for 2 years, with the latest figure at $675.34 in Q3 2010.
- Quarterly Minority Interest changed N/A year-over-year to $675.34 in Q3 2010, while the trailing twelve-month figure through Sep 2010 was $675.34 (changed N/A YoY) and the FY2009 annual result came in at $855.1, changed N/A from the prior year.
- Minority Interest fell to $675.34 in Q3 2010 per EVO's latest filing, from $1028.8 in the prior quarter.
- Over five years, Minority Interest peaked at $1028.8 in Q2 2010 and troughed at -$1039.2 in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 675.34 |
| Jun 30, 2010 | 1,028.79 |
| Mar 31, 2010 | 900.06 |
| Dec 31, 2009 | 905.24 |
| Aug 31, 2009 | -1,039.23 |